share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

SEC announcement ·  May 7 16:53
Summary by Moomoo AI
On May 3, 2024, Laura A. Williams, Chief Medical Officer of Ardelyx, Inc., completed a series of transactions involving the company's common stock. Williams exercised options to acquire 30,000 shares at a price of $0.99 per share. On the same day, she sold 39,949 shares at a market price of $8.35 per share, resulting in a total sale value of approximately $333,574. After these transactions, Williams held a total of 370,189 shares of Ardelyx common stock directly.
On May 3, 2024, Laura A. Williams, Chief Medical Officer of Ardelyx, Inc., completed a series of transactions involving the company's common stock. Williams exercised options to acquire 30,000 shares at a price of $0.99 per share. On the same day, she sold 39,949 shares at a market price of $8.35 per share, resulting in a total sale value of approximately $333,574. After these transactions, Williams held a total of 370,189 shares of Ardelyx common stock directly.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more